Pauline du Rusquec

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

J. Honnorat, O. Lambotte, F. Bourdain, 2019, Journal of Immunotherapy for Cancer.

Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data

M. Campone, J. Frenel, M. Robert, 2019, Cancer management and research.

Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer

M. Campone, J. Frenel, P. du Rusquec, 2020, Therapeutic advances in medical oncology.